Trade Beam Therapeutics Inc. - BEAM CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.12 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 33.09 |
| Open | 33.13 |
| 1-Year Change | 4.48% |
| Day's Range | 30.18 - 33.13 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 30.38 | -3.21 | -9.56% | 33.59 | 33.69 | 30.13 |
| Feb 20, 2025 | 33.09 | -1.24 | -3.61% | 34.33 | 34.41 | 32.85 |
| Feb 19, 2025 | 34.01 | 0.53 | 1.58% | 33.48 | 34.70 | 33.32 |
| Feb 18, 2025 | 33.41 | -0.12 | -0.36% | 33.53 | 35.15 | 32.98 |
| Feb 14, 2025 | 32.34 | 3.44 | 11.90% | 28.90 | 34.41 | 28.90 |
| Feb 13, 2025 | 28.56 | -0.04 | -0.14% | 28.60 | 29.14 | 27.73 |
| Feb 12, 2025 | 28.51 | 2.37 | 9.07% | 26.14 | 28.57 | 25.74 |
| Feb 11, 2025 | 26.81 | 0.88 | 3.39% | 25.93 | 26.87 | 25.25 |
| Feb 10, 2025 | 26.52 | -0.99 | -3.60% | 27.51 | 27.51 | 26.03 |
| Feb 7, 2025 | 27.33 | -0.12 | -0.44% | 27.45 | 27.83 | 26.83 |
| Feb 6, 2025 | 27.60 | -0.50 | -1.78% | 28.10 | 28.66 | 27.46 |
| Feb 5, 2025 | 27.76 | 1.76 | 6.77% | 26.00 | 27.84 | 25.70 |
| Feb 4, 2025 | 25.70 | 0.25 | 0.98% | 25.45 | 26.26 | 24.91 |
| Feb 3, 2025 | 25.53 | 0.58 | 2.32% | 24.95 | 25.89 | 24.25 |
| Jan 31, 2025 | 25.84 | -1.42 | -5.21% | 27.26 | 27.65 | 25.57 |
| Jan 30, 2025 | 27.24 | 0.97 | 3.69% | 26.27 | 27.87 | 26.11 |
| Jan 29, 2025 | 25.86 | 0.09 | 0.35% | 25.77 | 26.66 | 24.96 |
| Jan 28, 2025 | 25.21 | -0.35 | -1.37% | 25.56 | 25.89 | 24.70 |
| Jan 27, 2025 | 25.86 | 0.70 | 2.78% | 25.16 | 26.19 | 24.95 |
| Jan 24, 2025 | 25.93 | -0.27 | -1.03% | 26.20 | 26.66 | 25.46 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Beam Therapeutics Inc. Company profile
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children''s Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.| Industry: | Biotechnology & Medical Research (NEC) |
26 Landsdowne St
CAMBRIDGE
MASSACHUSETTS 02139-4216
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com